216 related articles for article (PubMed ID: 24746942)
1. The systemic exposure to inhaled beclometasone/formoterol pMDI with valved holding chamber is independent of age and body size.
Govoni M; Piccinno A; Lucci G; Poli G; Acerbi D; Baronio R; Singh D; Kuna P; Chawes BL; Bisgaard H
Pulm Pharmacol Ther; 2015 Feb; 30():102-9. PubMed ID: 24746942
[TBL] [Abstract][Full Text] [Related]
2. Systemic exposure to inhaled beclometasone/formoterol DPI is age and body size dependent.
Chawes BL; Govoni M; Kreiner-Møller E; Vissing NH; Poorisrisak P; Mortensen L; Nilsson E; Bisgaard A; Dossing A; Deleuran M; Skytt NL; Samandari N; Piccinno A; Sergio F; Ciurlia G; Poli G; Acerbi D; Singh D; Bisgaard H
Respir Med; 2014 Aug; 108(8):1108-16. PubMed ID: 24993817
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of an extrafine fixed pMDI combination of beclometasone dipropionate/formoterol fumarate in adolescent asthma.
Kuna P; Govoni M; Lucci G; Scuri M; Acerbi D; Stelmach I
Br J Clin Pharmacol; 2015 Sep; 80(3):569-80. PubMed ID: 25808292
[TBL] [Abstract][Full Text] [Related]
4. Effect of AeroChamber Plus™ on the lung and systemic bioavailability of beclometasone dipropionate/formoterol pMDI.
Singh D; Collarini S; Poli G; Acerbi D; Amadasi A; Rusca A
Br J Clin Pharmacol; 2011 Dec; 72(6):932-9. PubMed ID: 21615456
[TBL] [Abstract][Full Text] [Related]
5. Beclometasone dipropionate/formoterol: in an HFA-propelled pressurised metered-dose inhaler.
Dhillon S; Keating GM
Drugs; 2006; 66(11):1475-83; discussion 1484-5. PubMed ID: 16906779
[TBL] [Abstract][Full Text] [Related]
6. Bronchodilating effects of a new beclometasone dipropionate plus formoterol fumarate formulation via pressurized metered-dose inhaler in asthmatic children: a double-blind, randomized, cross-over clinical study.
Pohunek P; Varoli G; Reznichenko Y; Mokia-Serbina S; Brzostek J; Kostromina V; Kaladze M; Muraro A; Carzana E; Armani S; Kaczmarek J
Eur J Pediatr; 2021 May; 180(5):1467-1475. PubMed ID: 33404895
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic comparison of inhaled fixed combination vs. the free combination of beclomethasone and formoterol pMDIs in asthmatic children.
Chawes BL; Piccinno A; Kreiner-Møller E; Vissing NH; Poorisrisak P; Mortensen L; Nilson E; Bisgaard A; Dossing A; Deleuran M; Skytt NL; Samandari N; Sergio F; Ciurlia G; Poli G; Acerbi D; Bisgaard H
Br J Clin Pharmacol; 2013 Apr; 75(4):1081-8. PubMed ID: 22978252
[TBL] [Abstract][Full Text] [Related]
8. Lung function and asthma control with beclomethasone and formoterol in a single inhaler.
Huchon G; Magnussen H; Chuchalin A; Dymek L; Gonod FB; Bousquet J
Respir Med; 2009 Jan; 103(1):41-9. PubMed ID: 18977646
[TBL] [Abstract][Full Text] [Related]
9. Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial.
Papi A; Corradi M; Pigeon-Francisco C; Baronio R; Siergiejko Z; Petruzzelli S; Fabbri LM; Rabe KF
Lancet Respir Med; 2013 Mar; 1(1):23-31. PubMed ID: 24321801
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of extrafine beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide in adolescent and adult patients with asthma.
Kuna P; Jerzynska J; Martini M; Vele A; Barneschi I; Mariotti F; Georges G; Ciurlia G
Pharmacol Res Perspect; 2022 Aug; 10(4):e980. PubMed ID: 35733414
[TBL] [Abstract][Full Text] [Related]
11. Short-Term Growth During Treatment with Inhaled Fluticasone Propionate/Formoterol, Fluticasone and Beclomethasone Treatment.
Wolthers OD; Moore A; Mersmann S; Dissanayake S
J Aerosol Med Pulm Drug Deliv; 2017 Oct; 30(5):373-380. PubMed ID: 28510491
[TBL] [Abstract][Full Text] [Related]
12. Systemic exposure and implications for lung deposition with an extra-fine hydrofluoroalkane beclometasone dipropionate/formoterol fixed combination.
Bousquet J; Poli G; Acerbi D; Monno R; Ramael S; Nollevaux F
Clin Pharmacokinet; 2009; 48(6):347-58. PubMed ID: 19650674
[TBL] [Abstract][Full Text] [Related]
13. A valved holding chamber does not decrease the bronchodilator activity of budesonide-formoterol combination metered dose inhaler.
Mansfield LE; Maynes R
J Asthma; 2013 Feb; 50(1):71-4. PubMed ID: 23176189
[TBL] [Abstract][Full Text] [Related]
14. Inhaled beclometasone dipropionate/formoterol fumarate extrafine fixed combination for the treatment of asthma.
Crisafulli E; Zanini A; Pisi G; Pignatti P; Poli G; Scuri M; Chetta A
Expert Rev Respir Med; 2016; 10(5):481-90. PubMed ID: 26938578
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of budesonide and formoterol administered via 1 pressurized metered-dose inhaler in patients with asthma and COPD.
Tronde A; Gillen M; Borgström L; Lötvall J; Ankerst J
J Clin Pharmacol; 2008 Nov; 48(11):1300-8. PubMed ID: 18974284
[TBL] [Abstract][Full Text] [Related]
16. Inhaled beclometasone dipropionate/formoterol extra-fine fixed combination in the treatment of asthma: evidence and future perspectives.
Fabbri LM; Nicolini G; Olivieri D; Papi A
Expert Opin Pharmacother; 2008 Feb; 9(3):479-90. PubMed ID: 18220498
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro performance of three small-volume valved holding chambers with beclomethasone/formoterol pressurized metered dose inhaler.
Goncalves TM; Alhanout K; Nicolay A; Dubus JC; de Santana DP; Andrieu V
J Aerosol Med Pulm Drug Deliv; 2013 Aug; 26(4):223-7. PubMed ID: 23094686
[TBL] [Abstract][Full Text] [Related]
18. A clinical pharmacology study of fixed vs. free combination of inhaled beclometasone dipropionate and formoterol fumarate dry powder inhalers in asthmatic adolescents.
Chawes BL; Govoni M; Piccinno A; Kreiner-Møller E; Vissing NH; Mortensen L; Nilsson E; Bisgaard A; Deleuran M; Skytt N; Samandari N; Acerbi D; Bisgaard H
Br J Clin Pharmacol; 2014 Nov; 78(5):1169-71. PubMed ID: 24830339
[No Abstract] [Full Text] [Related]
19. Extrafine beclomethasone/formoterol combination via a dry powder inhaler (NEXThaler(®)) or pMDI and beclomethasone monotherapy for maintenance of asthma control in adult patients: A randomised, double-blind trial.
Kanniess F; Scuri M; Vezzoli S; Francisco C; Petruzzelli S
Pulm Pharmacol Ther; 2015 Feb; 30():121-7. PubMed ID: 25088067
[TBL] [Abstract][Full Text] [Related]
20. The functionality of a budesonide/formoterol pressurized metered-dose inhaler with an integrated actuation counter.
Shah S; White M; Uryniak T; O'Brien CD
Allergy Asthma Proc; 2010; 31(1):40-8. PubMed ID: 20167144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
